BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11789029)

  • 1. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
    DeNardo DG; Xiong CY; Shi XB; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Dec; 16(6):525-35. PubMed ID: 11789029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
    DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT.
    DeNardo SJ; DeNardo GL; Brush J; Carter P
    Hybridoma; 1999 Feb; 18(1):13-21. PubMed ID: 10211783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.
    Winthrop MD; DeNardo SJ; DeNardo GL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3088s-3094s. PubMed ID: 10541348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
    Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
    Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.
    Korn T; Nettelbeck DM; Völkel T; Müller R; Kontermann RE
    J Gene Med; 2004 Jun; 6(6):642-51. PubMed ID: 15170735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.
    Yazaki PJ; Lee B; Channappa D; Cheung CW; Crow D; Chea J; Poku E; Li L; Andersen JT; Sandlie I; Orcutt KD; Wittrup KD; Shively JE; Raubitschek A; Colcher D
    Protein Eng Des Sel; 2013 Mar; 26(3):187-93. PubMed ID: 23175797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
    Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
    Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
    MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
    Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.
    McGuinness BT; Walter G; FitzGerald K; Schuler P; Mahoney W; Duncan AR; Hoogenboom HR
    Nat Biotechnol; 1996 Sep; 14(9):1149-54. PubMed ID: 9631069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of humanized anti-digoxin scFv and diabody].
    Chen YP; Zhang GM; Qiao YY; Wang G; Liu YF; Hua B; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):710-3. PubMed ID: 16256033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.
    McCall AM; Adams GP; Amoroso AR; Nielsen UB; Zhang L; Horak E; Simmons H; Schier R; Marks JD; Weiner LM
    Mol Immunol; 1999 May; 36(7):433-45. PubMed ID: 10449096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and screening of phage antibody libraries against epidermal growth factor receptor and soluble expression of single chain Fv].
    Sheng WJ; Miao QF; Zhen YS
    Yao Xue Xue Bao; 2009 Jun; 44(6):597-602. PubMed ID: 19806889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.